ACT correlation_ Hemochron vs istat
16 followers
5 Likes
+ 2 more
Good Morning Friends!
We are really struggling as we perform ACT testing on 3 different platforms; istat ACT, Hemochron ACT LR, and Hemochron ACTPlus. CAP informed us that we DO need to correlate all 3 of these at the same time however I truly disagree (as they are 'apples to oranges'). Werfen/Hemochron states that by design, the ACT+ and the ACT LR are NOT interchangeable because each cartridge has a different sensitivity to unfractioned heparin. Basically, the plus cartridge should be used with high doses of UFH (1-6 units ml/blood) and that the LR cartridge should be used for low to mid does (only up to 2.5 units ml/blood). The also have different activators, ACT Plus uses Kaolin and the LR uses Celite.
And throwing the istat into the ring, i thas been proven to consistently show significantly lower ACT values than ACT Plus. i-STAT quantifies thrombin formation occurring in an earlier phase in the anticoagulation cascade, unlike the ACT Plus which assesses physical clot formation. Based on these results, kaolin-activated point-of-care ACT devices cannot be used interchangeably. Device-specific predefined target values are used to avert overly dosing heparin during CPB.
Unfortunately a 'gold standard' does not exist for ACT testing assessment. If anyone has input, please feel free to contact me directly or share here!
Thanks so much,
Danialle
We are really struggling as we perform ACT testing on 3 different platforms; istat ACT, Hemochron ACT LR, and Hemochron ACTPlus. CAP informed us that we DO need to correlate all 3 of these at the same time however I truly disagree (as they are 'apples to oranges'). Werfen/Hemochron states that by design, the ACT+ and the ACT LR are NOT interchangeable because each cartridge has a different sensitivity to unfractioned heparin. Basically, the plus cartridge should be used with high doses of UFH (1-6 units ml/blood) and that the LR cartridge should be used for low to mid does (only up to 2.5 units ml/blood). The also have different activators, ACT Plus uses Kaolin and the LR uses Celite.
And throwing the istat into the ring, i thas been proven to consistently show significantly lower ACT values than ACT Plus. i-STAT quantifies thrombin formation occurring in an earlier phase in the anticoagulation cascade, unlike the ACT Plus which assesses physical clot formation. Based on these results, kaolin-activated point-of-care ACT devices cannot be used interchangeably. Device-specific predefined target values are used to avert overly dosing heparin during CPB.
Unfortunately a 'gold standard' does not exist for ACT testing assessment. If anyone has input, please feel free to contact me directly or share here!
Thanks so much,
Danialle
12 Replies
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Suggested Posts
Topic | Replies | Likes | Views | Participants | Last Reply |
---|---|---|---|---|---|
Best practice for epoc usage | 1 | 0 | 217 | ||
Intraoperative PTH | 1 | 0 | 270 | ||
ACT correlation_ Hemochron vs istat | 12 | 5 | 990 |
They are not the same test; even though they share the same name. We have ACTLR and ACT+ on the new GEM100s and I correlate the + and LR assays across all devices, but not one assay to the other. I have lots of heparin response curves I've been collecting over the years and its very fascinating to superimpose a + and LR response curve, same donor or not. This visual should be more than clear enough to demonstrate that the assays are not the same. There are some in the cuvette package inserts, too.
Good luck. Please keep us posted on developments. Feel free to email me.
We sat in on four EP cases, each with an average of 7 draws per patient over the course of their procedure -two male and two female just to keep it on the up and up. I love this job, so fun! So what we found was, the iSTAT ACTk set to Non-Warm matched almost perfectly with Old-Man Hemochron Celite Tube method - the method from which all cardiologists on earth have set their target ranges for anticoagulation using heparin since the dawn of time. Those targets have not changed, what has is the instruments created to make measuring ACT faster - basically all automated ACT methods are now just calculations, and unfortunately those calculations are all different and have different use cases. In our case, we were happy with the iSTAT ACTk set to Non-Warm mode and henceforth all of those hospitals have used it without issue or complaint. Every so often we hear about the new guy that used the faster Hemocrhon Jr's in his old job and insists on using them now, and we have to bust out the old study we did showing him he's wrong and such :) Kidding! You can correlate two things, and that doesn't mean equal. It can show they both go up with higher levels of heparin at the same rate, but do not give the same exact number, and that is fine - just explain that in your correlation study results. BUt also think about use case - as mentioned, using ACT during CPB is vastly different than using ACT in an EP case - choose accordingly. If one is specifically designed for high dose, then only compare to another high dose cartridge and vsv. Another place we looked was in the peer data from our CAP surveys and compared the SD and %CV for each method listed above. At that time, Hepcon was the best, iSTAT was second best, and Hemochron Jr was the worst - but we all know what those Hemochron Jr CAP specimens were like - you needed to do it just perfectly, or it was trash. So I digress. We plotted our data using EP Evaluator Multiple Instrument Comparison, and had the values from the Hemochron Response as the target. iSTAT ACTk Non-Warm was nearly identical, followed closely by Hepcon, then iSTAT ACTk in Prewarm showed a consistent negative bias, and Hemochron Jr. Signature ACT+ showed a consistent positive bias with some pretty crazy outliers to boot. That is how we convinced 500 cardiologists across 17 hospitals to change to iSTAT for EP/Cath - and were happy to keep our Hepcons in the OR for CPB. The end.
Ms. Clark - thank you for sharing this in depth information. I learned quite a bit that I was not aware of!
We are also currently having this issue in our Cathlab thinking they are using more heparin lately with the i-Stat ACT-k than when they had Hemochron LR. We are actively doing a 30 patient correlation study to our aPTT vs. the i-Stat value to prove to the docs that they need to adjust their cutoff values lower to than what they have been using. It is insanely time consuming - but fun to sit in on PCI's and assist with this study.
What we are seeing is most of the time the docs are waiting 10-15mins after dosing heparin before running the ACT. Abbott is recommending 5 mins post dosing as the ideal time frame, especially since it may take the doc an additional minute or three before they are able to get to drawing a blood sample while in the middle of PCI. I am looking forward to collecting data on ACTs performed clsoer to the 5 minute mark to see if they are closer to that magical 250seconds my docs seem to be targeting.
SIlka - would you be willing to share your study results? - I am particularly interested in the pre-warm vs. non-warm mode on both i-Stat machines. What a great study you were able to perform - you should consider publishing it (if you haven't already)!